Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death

被引:0
|
作者
A Kohno
N Emi
M Kasai
M Tanimoto
H Saito
机构
[1] Nagoya University School of Medicine,First Department of Internal Medicine
来源
Gene Therapy | 1998年 / 5卷
关键词
self-amplifying vector; Semliki Forest virus; plasmid vector;
D O I
暂无
中图分类号
学科分类号
摘要
We have constructed a novel DNA expression vector based on Semliki Forest virus (SFV). SFV produces nonstructural proteins (nsPs) which replicate genomic RNA and amplify the mRNA encoding the structural proteins of SFV. A recombinant cDNA genome of SFV, in which the SFV structural genes were replaced by a polylinker cassette to allow for insertion of heterologous DNA, was placed under the control of a cytomegalovirus immediate–early enhancer/promoter with a polyadenylation signal. Transfection of mammalian cells with this SFV-based plasmid vector, pSFV3-CMV-lacZ-pA, resulted in transient high-level expression of a β-galactosidase reporter gene. The expression level of β-galactosidase from pSFV3-CMV-lacZ-pA was more than 20-fold higher than that obtained from the plasmid with deleted nsPs genes, pSFV3A5976-lacZ, demonstrating that the nsPs genes were essential for the high level of expression. Substantial β-galactosidase activity was detected in the medium of pSFV3-CMV-lacZ-pA-transfected cells, suggesting that the overproduction of β-galactosidase caused cell death and release of the protein into the medium. We have demonstrated a high-level expression of the exogenous β-galactosidase gene from pSFV3-CMV-lacZ-pA constructed using an SFV replication system.
引用
收藏
页码:415 / 418
页数:3
相关论文
共 50 条
  • [1] Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death
    Kohno, A
    Emi, N
    Kasai, M
    Tanimoto, M
    Saito, H
    GENE THERAPY, 1998, 5 (03) : 415 - 418
  • [2] Semliki Forest Virus-Based Expression of Recombinant GPCRs
    Lundstrom, Kenneth
    MEMBRANE PROTEINS - PRODUCTION AND FUNCTIONAL CHARACTERIZATION, 2015, 556 : 331 - 350
  • [3] Semliki Forest virus-based immunotherapy for cancer
    Lundstrom, Kenneth
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 593 - 599
  • [4] Semliki forest virus-based expression for versatile use in receptor research
    Lundstrom, K
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2002, 22 (1-4): : 229 - 240
  • [5] Semliki Forest virus as an expression vector in insect cell lines
    Pettigrew, MM
    O'Neill, SL
    INSECT MOLECULAR BIOLOGY, 1999, 8 (03) : 409 - 414
  • [6] Optimization of a GDNF production method based on Semliki Forest virus vector
    Torres-Ortega, Pablo Vicente
    Smerdou, Cristian
    Ansorena, Eduardo
    Ballesteros-Briones, Maria Cristina
    Martisova, Eva
    Garbayo, Elisa
    Blanco-Prieto, Maria J.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 159
  • [7] Recombinant protein production using the Semliki Forest Virus expression system
    H.D. Blasey
    K. Lundström
    S. Tate
    A.R. Bernard
    Cytotechnology, 1997, 24 : 65 - 72
  • [8] Recombinant protein production using the Semliki Forest Virus expression system
    Blasey, HD
    Lundstrom, K
    Tate, S
    Bernard, AR
    CYTOTECHNOLOGY, 1997, 24 (01) : 65 - 72
  • [9] Human MxA protein confers resistance to semliki forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins
    Landis, H
    Simon-Jödicke, A
    Klöti, A
    Di Paolo, C
    Schnorr, JJ
    Schneider-Schaulies, S
    Hefti, HP
    Pavlovic, J
    JOURNAL OF VIROLOGY, 1998, 72 (02) : 1516 - 1522
  • [10] Development of a next generation Semliki Forest virus-based DNA vaccine against cervical cancer
    van de Wall, Stephanie
    Ljungberg, Karl
    Peng, Peng I. P.
    Boerma, Annemarie
    Nijman, Hans W.
    Liljestrom, Peter
    Daemen, Toos
    HUMAN GENE THERAPY, 2014, 25 (11) : A30 - A30